Plain-English translation of NCT06881043 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether robot-assisted surgery using the Vessel Sealer Extend device is safe and effective for treating locally advanced stomach cancer. The study compares this newer robotic approach to traditional laparoscopic (minimally invasive) surgery. Researchers want to see if the robotic system—which offers better precision, magnification, and steadier instrument control—leads to better outcomes and fewer complications.
Stomach cancer surgery is challenging because surgeons must carefully remove lymph nodes and surrounding tissue without damaging nearby organs like the pancreas. Traditional laparoscopic surgery has limitations in precision and flexibility that can sometimes lead to serious complications, such as pancreatic injury. This trial exists to see whether robotic assistance improves safety and surgical outcomes for patients with advanced stomach cancer.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo robot-assisted radical gastrectomy (stomach removal) or traditional laparoscopic surgery, depending on which group you are assigned to. Before surgery, you will have detailed imaging scans and medical evaluations. After surgery, the research team will monitor your recovery, track complications, and assess surgical outcomes like how well the lymph nodes were removed and whether pancreatic injury occurred. The study involves about 300 patients total across multiple hospitals.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
China